Generare Bioscience
GB
GE
Generare Bioscience
Generating never-before-seen molecular data for drug development using artificial intelligence.
About
Generare Bioscience is a biotechnology company focused on generating novel molecular data for drug development. They leverage artificial intelligence to discover and advance new drugs.
Competitors & alternatives (6)
Generare Bioscience alternatives Key facts
At-a-glance profile data
- Headquarters
- Paris, France
- Founded
- 2023
- Total funding
- $23M (Series A)
- Business model
- B2B
Funding rounds
Add first review
Frequently asked
How much funding has Generare Bioscience raised?
Generare Bioscience has raised a total of $23M in funding. The most recent round on record is Series A.